NOV 19, 2015 9:20 AM PST

Finally Catching Small Cell Lung Cancer Before Metastasis

WRITTEN BY: Kara Marker
Small cell lung cancer (SCLC) has a long history of evading both the immune system and scientists trying to study how it does so, and patients with SCLC rarely get diagnosed before the cancer has metastasized. Scientists from the Medical University of Vienna in Austria, where increasing amounts of people are dying from lung cancer, were finally able to obtain enough cancer cell material to determine how these tumors remain so pervasive. Dr. Gerhard Hamilton, leader of the study, and his team published their findings this week in OncoImmunology.

Difficulty in SCLC detection most often leads to poor prognoses and harsh treatments. Irradiation and cytotoxic chemotherapy are the only options, since surgery is ineffective. Cytotoxic chemotherapy drugs are injected into the bloodstream with the goal of impeding cancer cell ability to divide and grow, leading to their destruction (Northern Health and Social Care Trust). Normal human cells also need to divide and grow to survive though, so this therapy often has unfortunate side effects for cancer patients. In both Austria and America where lung cancer kills thousands of people every year, about 15% of lung cancers are diagnosed as SCLC, most often in people who have a history of smoking (Cancer.org). 

Scientists studying SCLC constantly had trouble obtaining "enough cell material available for biomolecular analysis," a major roadblock in figuring out how tumors would shrink initially after chemotherapy and then return resistant to the harshest treatments. In developing a new method for obtaining and cultivating samples for study, Hamilton and his team have made major advances in the battle against SCLC.

Their established method for "cultivating the circulating tumor cells (CTCs)" made it possible for the team to determine the mechanisms behind the cancer cells' immune system evasion.

First, CTCs manipulate the local microenvironment to stimulate monocyte differentiation into macrophages. At first this seems counterintuitive since macrophages function to phagocytose abnormal cells like tumor cells. However, CTCs also alter macrophage cytokine expression to the point where the lymphocytes not only fail to attack and kill the cancerous cells, but also change the local conditions themselves to enhance CTCs' ability to spread.

In the words of the scientific team, "CTCs are competent to specifically manipulate tumor-associated macrophages to increase invasiveness, angiogenesis, immunosuppression, and possibly lipid catabolism."

Now that the team from Vienna understands monumentally more about SCLC evasion of the immune system, the next step is to determine how cancer recurrence is accompanied by resistance to treatment. 

Watch the following video to learn more about how SCLC is diagnosed and how doctors create treatment plans.

Source: University Department of Surgery at the Medical University of Vienna



 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 19, 2020
Immunology
Cancer Mutation Improves Chemo Drug Performance
AUG 19, 2020
Cancer Mutation Improves Chemo Drug Performance
When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcom ...
SEP 01, 2020
Immunology
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
SEP 01, 2020
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
Malaria is one of the biggest ongoing threats to global health — over 200 million were infected and almost half a ...
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
Loading Comments...